Unlocking the strategic value of freedom to operate

Live webinar

15 October 2020
10:00 a.m. - 11:00 a.m. PST

Registration for this event is closed.

Questions? Please feel free to contact Riannah Reagh.

Download or print PDF

For any organization invested in research and development, IP landscaping and Freedom to Operate (FTO) analysis can serve as a vital roadmap as you bring your product to life – and finally to market.

On October 15, join LifeSciences BC and members of Gowling WLG’s Life Sciences Group along with Ben Thiede of Stemcell Technologies, as together they explore strategies for managing IP risks and opportunities in an innovative life sciences enterprise.

Introduction: Wendy Hurlburt, CEO, LSBC

Moderator: Lisa Thorne

Panel members: Brian Kingwell, Edith Penty Geraets and Ben Thiede from Stemcell Technologies

Missed the webinar? View it on-demand now »

Event contact

Riannah Reagh
Business Development & Marketing Coordinator

Share this event

Would a colleague be interested in this event? You can share this event using the following links.